Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Macrogenics (MGNX) over the last 14 years, with Q2 2025 value amounting to $69.7 million.

  • Macrogenics' Cash from Financing Activities rose 1105824.0% to $69.7 million in Q2 2025 from the same period last year, while for Sep 2025 it was $69.6 million, marking a year-over-year increase of 635751.39%. This contributed to the annual value of $960000.0 for FY2024, which is 9936.15% down from last year.
  • According to the latest figures from Q2 2025, Macrogenics' Cash from Financing Activities is $69.7 million, which was up 1105824.0% from -$282000.0 recorded in Q1 2025.
  • Macrogenics' Cash from Financing Activities' 5-year high stood at $100.7 million during Q1 2021, with a 5-year trough of -$282000.0 in Q1 2025.
  • Its 5-year average for Cash from Financing Activities is $20.3 million, with a median of $625000.0 in 2024.
  • In the last 5 years, Macrogenics' Cash from Financing Activities skyrocketed by 27048918.92% in 2023 and then plummeted by 21370.97% in 2025.
  • Quarter analysis of 5 years shows Macrogenics' Cash from Financing Activities stood at $800000.0 in 2021, then soared by 69.88% to $1.4 million in 2022, then plummeted by 79.91% to $273000.0 in 2023, then tumbled by 43.22% to $155000.0 in 2024, then surged by 44892.9% to $69.7 million in 2025.
  • Its Cash from Financing Activities was $69.7 million in Q2 2025, compared to -$282000.0 in Q1 2025 and $155000.0 in Q4 2024.